08/01/2015

iSatori Launches Two New Products, Hyper-Gro™ and Pre-Gro™ -- Fortified With Their Category-Defining Muscle-Building Innovation Bio-Gro™ Bio-Active Peptides -- Expected to Revolutionize Top Sports Nutrition Categories

iSatori©
GOLDEN, CO--(Jan 5, 2015) - iSatori, Inc. (OTCQB: IFIT), an emerging leader in the development and marketing of scientifically engineered nutritional supplements for healthier lifestyles, today announced two additional new products containing Bio-Gro™ -- their category-defining innovation called "bio-active peptides" -- into Pre-Gro™ and Hyper-Gro™ to further expand their brand and significantly increase distribution by the world's largest sports nutrition retailers.

Stephen Adele, iSatori founder and Chief Executive Officer, commented, "When we launched Bio-Gro in 2013, it quickly exceeded our expectations and forecasts, based on consumer satisfaction and demand. After the original clinical studies were conducted, we knew Bio-Gro had many applications and could be incorporated into other products to help our customers gain new muscle size and strength, as well as maximize our IP surrounding bio-active peptides."

Adele continued, "This is why we forged ahead with our research and development efforts to formulate Hyper-Gro™, a new lean mass gainer shake, and Pre-Gro™, a muscle-building pre-workout igniter. They will be the only products, within their respective categories, that exclusively contain our patent-pending Bio-Gro bio-active peptides."

Hyper-Gro™ and Pre-Gro™ will compete within the two largest, highest volume categories within the $35-billion nutritional supplements sector. With these new product innovations, iSatori has set the stage for continued growing interest from retailers and consumers alike and further sets itself apart in developing truly innovative and highly differentiated supplements for natural weight trainers and health-conscience fitness enthusiasts.

VP of Marketing at iSatori, Craig Stevenson, added, "We are introducing the two newest iSatori products, Hyper-Gro™ and Pre-Gro™, to over 20,000 retail stores around the globe, including GNC, Vitamin Shoppe, and Bodybuilding.com, which are all at the forefront of the launch. We're confident we have provided significant advancement in the two largest sports supplement categories, which will give iSatori a strong advantage as we go to market and utilize our patent-pending intellectual property surrounding bio-active peptides."

Customers will soon find Hyper-Gro™ and Pre-Gro™ nationally at GNC, The Vitamin Shoppe, and at top retail websites like GNC.com, Bodybuilding.com, TigerFitness.com, MuscleandStrength.com, CampusProtein.com, and hundreds more.

To learn more about iSatori and Hyper-Gro™ and Pre-Gro™, visit www.iSatori.com/Grotime; or for more in-depth science on Bio-Gro™ bio-active peptides, visit www.bio-gro.org. As the exclusive distributor of Hyper-Gro and Pre-Gro, Europa Sports supplies over 14,000 specialty and independent retailers. Retailers interested in carrying these two latest iSatori innovations can contact Europa Sports at 1-800-447-4795 or visit www.EuropaSports.com.

To sign up to receive iSatori's most recent news and updates via email, please visit http://www.isatori.com/Email-Signup-C2041.aspx.

About iSatori, Inc.

iSatori is a consumer products firm that develops and sells nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. The Company is headquartered in Golden, Colorado, and its common stock trades on the OTCQB under the symbol "IFIT."

More information about the Company is available at http://www.isatori.com.

Forward-Looking Statements

Statements made in this news release relating to the Company's future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We have used the words "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will," "potential," and similar terms and phrases to identify forward-looking statements in this press release. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management's assumptions and the Company's future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company's products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. Please see our Risk Factor disclosures included in our Registration Statement on Form S-1, as amended, initially filed with the Securities and Exchange Commission on April 30, 2013, and in subsequent filings with the Securities and Exchange Commission. All future written or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the previous statements. The forward-looking statements herein speak as of the date of this press release. We undertake no obligation to update any information contained herein or to publicly release the results of any revisions to any forward-looking statements that may be made to reflect events or circumstances that occur, or that we become aware of, after the date of this press release.

Individual results will vary. Always consult a physician prior to starting any diet or exercise program. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.


Source iSatori Inc. through Marketwired by press release ©

Aucun commentaire:

Enregistrer un commentaire